NL6607516A - - Google Patents

Info

Publication number
NL6607516A
NL6607516A NL6607516A NL6607516A NL6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A
Authority
NL
Netherlands
Application number
NL6607516A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NL6607516A priority Critical patent/NL6607516A/xx
Priority to FR82837A priority patent/FR5953M/fr
Priority to GB22620/67A priority patent/GB1131007A/en
Priority to SE06961/67A priority patent/SE354417B/xx
Priority to IL28009A priority patent/IL28009A/en
Priority to GR670133861A priority patent/GR33861B/el
Priority to ES340956A priority patent/ES340956A1/es
Priority to SU1158241A priority patent/SU510986A3/ru
Priority to US641483A priority patent/US3557280A/en
Priority to BE699091D priority patent/BE699091A/xx
Priority to DE1617576A priority patent/DE1617576C3/de
Priority to FI1517/67A priority patent/FI43622B/fi
Priority to AT502267A priority patent/AT272522B/de
Priority to FR108345A priority patent/FR1529966A/fr
Priority to NO00168375A priority patent/NO126298B/no
Priority to IT37118/67A priority patent/IT1140250B/it
Priority to DK282167AA priority patent/DK117587B/da
Priority to YU1086/67A priority patent/YU31326B/xx
Priority to CS3970A priority patent/CS151454B2/cs
Priority to LU53788A priority patent/LU53788A1/xx
Priority to JP42034292A priority patent/JPS5010373B1/ja
Priority to CH766867A priority patent/CH490087A/de
Publication of NL6607516A publication Critical patent/NL6607516A/xx
Priority to MY15/71A priority patent/MY7100015A/xx
Priority to US05/267,087 priority patent/US3957972A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL6607516A 1966-05-31 1966-05-31 NL6607516A (OSRAM)

Priority Applications (24)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (OSRAM) 1966-05-31 1966-05-31
FR82837A FR5953M (OSRAM) 1966-05-31 1966-11-08
GB22620/67A GB1131007A (en) 1966-05-31 1967-05-16 Improvements in or relating to aqueous solutions of oxytetracycline
SE06961/67A SE354417B (OSRAM) 1966-05-31 1967-05-18
IL28009A IL28009A (en) 1966-05-31 1967-05-18 Process for the preparation of stable solutions of oxytetracycline in water,suitable for parenteral and peroral administration
GR670133861A GR33861B (el) 1966-05-31 1967-05-22 Μεθοδος δια την παρασκευην σταθερων εν των υδατι διαλυματων οξυτερακυκλινης, καταλληλων δια την παρεντερικην και την δια του στοματος χορηγησιν.
ES340956A ES340956A1 (es) 1966-05-31 1967-05-24 Procedimiento para la preparacion de soluciones estables deoxitetraciclina en agua adecuadas para administracion paren-teral, peronal y local.
SU1158241A SU510986A3 (ru) 1966-05-31 1967-05-25 Способ получени раствора окситетрациклина
US641483A US3557280A (en) 1966-05-31 1967-05-26 Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
BE699091D BE699091A (OSRAM) 1966-05-31 1967-05-26
DE1617576A DE1617576C3 (de) 1966-05-31 1967-05-26 Verfahren zur Herstellung eines Injektionspräparates auf Basis einer wäßrigen Lösung eines Oxytetracyclin-Magnesium-Komplexes
FI1517/67A FI43622B (OSRAM) 1966-05-31 1967-05-30
AT502267A AT272522B (de) 1966-05-31 1967-05-30 Verfahren zur Herstellung von stabilen, für die parenterale und perorale Verabreichung geeigneten wässerigen Lösungen von Oxytetracyclin
FR108345A FR1529966A (fr) 1966-05-31 1967-05-30 Procédé de préparation de solutions aqueuses stables d'oxytétracycline
NO00168375A NO126298B (OSRAM) 1966-05-31 1967-05-30
IT37118/67A IT1140250B (it) 1966-05-31 1967-05-30 Procedimento per la preparazione di soluzioni stabili di ossitetraciclina in acqua, adatte per somministrazioni per via parenterale ed orale
DK282167AA DK117587B (da) 1966-05-31 1967-05-30 Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.
YU1086/67A YU31326B (en) 1966-05-31 1967-05-30 Postupak za dobijanje stabilnog vodenog rastvora oksitetraciklina pogodnog za parenteralnu, peroralnu i lokalnu upotrebu
CS3970A CS151454B2 (OSRAM) 1966-05-31 1967-05-31
LU53788A LU53788A1 (OSRAM) 1966-05-31 1967-05-31
JP42034292A JPS5010373B1 (OSRAM) 1966-05-31 1967-05-31
CH766867A CH490087A (de) 1966-05-31 1967-05-31 Verfahren zur Herstellung von stabilen, für die parenterale, perorale und lokale Verabreichung geeigneten wässrigen Oxytetracyclinlösungen
MY15/71A MY7100015A (en) 1966-05-31 1971-12-30 Improvements in or relating to aqueous solutions of oxytetracycline
US05/267,087 US3957972A (en) 1966-05-31 1972-06-28 Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (OSRAM) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
NL6607516A true NL6607516A (OSRAM) 1967-12-01

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6607516A NL6607516A (OSRAM) 1966-05-31 1966-05-31

Country Status (22)

Country Link
US (1) US3557280A (OSRAM)
JP (1) JPS5010373B1 (OSRAM)
AT (1) AT272522B (OSRAM)
BE (1) BE699091A (OSRAM)
CH (1) CH490087A (OSRAM)
CS (1) CS151454B2 (OSRAM)
DE (1) DE1617576C3 (OSRAM)
DK (1) DK117587B (OSRAM)
ES (1) ES340956A1 (OSRAM)
FI (1) FI43622B (OSRAM)
FR (1) FR5953M (OSRAM)
GB (1) GB1131007A (OSRAM)
GR (1) GR33861B (OSRAM)
IL (1) IL28009A (OSRAM)
IT (1) IT1140250B (OSRAM)
LU (1) LU53788A1 (OSRAM)
MY (1) MY7100015A (OSRAM)
NL (1) NL6607516A (OSRAM)
NO (1) NO126298B (OSRAM)
SE (1) SE354417B (OSRAM)
SU (1) SU510986A3 (OSRAM)
YU (1) YU31326B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615140A1 (de) * 1975-04-11 1976-10-21 Nelson Res & Dev Vehiculumsystem

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (OSRAM) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
CZ301835B6 (cs) 1999-09-14 2010-07-07 Trustees Of Tufts College Zpusob prípravy 7-, 9- nebo 13- substituované tetracyklinové slouceniny, reaktivní tetracyklinový chemický komplex a tetracyklinová sloucenina substituovaná v poloze 7 nebo 9
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6833365B2 (en) 2000-01-24 2004-12-21 Trustees Of Tufts College Tetracycline compounds for treatment of Cryptosporidium parvum related disorders
DE60129116T2 (de) 2000-03-31 2008-03-13 Trustees Of Tufts College, Medford 7- und 9-carbamat, harnstoff, thioharnstoff, thiocarbamat und heteroaryl-amino substituierte tetracyclinverbindungen
CA2409063A1 (en) * 2000-05-15 2001-11-22 Mark L. Nelson 7-substituted fused ring tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
AU2001268475A1 (en) * 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
JP4963771B2 (ja) 2000-07-07 2012-06-27 トラスティーズ・オブ・タフツ・カレッジ ７、８および９−置換テトラサイクリン化合物
CN1452611A (zh) 2000-07-07 2003-10-29 塔夫茨大学信托人 13－取代甲烯土霉素化合物
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
KR101027625B1 (ko) 2000-07-07 2011-04-06 파라테크 파마슈티컬스, 인크. 7-치환 테트라사이클린 화합물
AU2001286388B2 (en) 2000-07-07 2005-07-14 Paratek Pharmaceuticals, Inc. 9-substituted minocycline compounds
HUP0402047A3 (en) 2001-03-13 2012-10-29 Paratek Pharmaceuticals 7,9-substituted tetracycline compounds, their use and pharmaceutical compositions containing them
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
US7045507B2 (en) 2001-03-14 2006-05-16 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
EP1379255A2 (en) 2001-03-14 2004-01-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
AU2002254714C1 (en) 2001-04-24 2010-01-07 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP2322501B1 (en) 2002-01-08 2015-08-05 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
KR101014918B1 (ko) 2002-03-08 2011-02-15 파라테크 파마슈티컬스, 인크. 아미노-메틸 치환된 테트라시클린 화합물
EP2481723A3 (en) 2002-03-21 2013-02-13 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP2345637A3 (en) 2002-07-12 2012-02-15 Paratek Pharmaceuticals, Inc. 3, 10, and 12a substituted tetracycline compounds
EP2277504A1 (en) 2002-10-24 2011-01-26 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
AU2003261633A1 (en) * 2003-02-12 2004-09-06 R And P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
CA2531728A1 (en) 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
WO2005070878A1 (en) * 2004-01-15 2005-08-04 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2269978A3 (en) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP1805134B1 (en) 2004-10-25 2012-06-20 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
AU2006210406C1 (en) 2005-02-04 2013-03-07 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
WO2007014154A2 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
WO2007035448A2 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
AU2007208214B2 (en) 2006-01-24 2013-02-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
EP2007713A2 (en) * 2006-04-17 2008-12-31 Teva Pharmaceutical Industries Ltd Isolation of tetracycline derivatives
ES2622356T3 (es) * 2006-04-24 2017-07-06 Teva Pharmaceutical Industries, Ltd. Formas cristalinas de tigeciclina y procesos para su preparación
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
JP2009537139A (ja) * 2006-05-15 2009-10-29 パラテック ファーマシューティカルズ インコーポレイテッド 置換されたテトラサイクリン化合物を用いて、遺伝子または遺伝子産物の発現を制御する方法
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
TR201818983T4 (tr) 2006-12-21 2019-01-21 Paratek Pharm Innc İnflamatuvar Cilt Bozukluklarının Tedavisine Yönelik Olarak Sübstitüe Edilmiş Tetrasiklin Bileşikleri
IL302749A (en) 2006-12-21 2023-07-01 Paratek Pharm Innc A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition
EP2144614A1 (en) * 2007-04-12 2010-01-20 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
EP2213655A1 (en) 2007-04-27 2010-08-04 Paratek Pharmaceuticals, Inc. Methods For Purifying Aminoalkyl Tetracycline Compounds
CN101811980A (zh) 2007-07-06 2010-08-25 帕拉特克药品公司 合成取代的四环素化合物的方法
MX2010009693A (es) 2008-03-05 2010-12-20 Paratek Pharm Innc Compuestos de monociclina y metodos de uso de la misma.
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
WO2009128913A1 (en) * 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
TW202216656A (zh) 2008-05-19 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
US9629806B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EP2341771A4 (en) * 2008-09-19 2012-08-15 Paratek Pharm Innc TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND RELATED THERAPEUTIC METHODS
EP2990051B1 (en) 2009-04-10 2016-10-26 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
HRP20191295T8 (hr) 2011-05-12 2020-02-07 Paratek Pharmaceuticals, Inc. Kristalne soli amida (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksilne kiseline i postupci uporabe istih
BR112019008897A2 (pt) 2016-11-01 2019-08-13 Paratek Pharm Innc método para tratar pneumonia bacteriana adquirida na comunidade.
AU2018303807B2 (en) 2017-07-21 2023-08-24 Almirall, Llc Treatment of non-inflammatory lesions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615140A1 (de) * 1975-04-11 1976-10-21 Nelson Res & Dev Vehiculumsystem

Also Published As

Publication number Publication date
FR5953M (OSRAM) 1968-04-16
IT1140250B (it) 1986-09-24
IL28009A (en) 1970-08-19
CS151454B2 (OSRAM) 1973-10-19
FI43622B (OSRAM) 1971-02-01
JPS5010373B1 (OSRAM) 1975-04-21
DE1617576B2 (de) 1980-04-10
AT272522B (de) 1969-07-10
YU31326B (en) 1973-04-30
LU53788A1 (OSRAM) 1967-07-31
SE354417B (OSRAM) 1973-03-12
CH490087A (de) 1970-05-15
ES340956A1 (es) 1968-06-16
DK117587B (da) 1970-05-11
GB1131007A (en) 1968-10-16
GR33861B (el) 1968-02-09
BE699091A (OSRAM) 1967-11-27
DE1617576C3 (de) 1980-12-11
SU510986A3 (ru) 1976-04-15
DE1617576A1 (de) 1972-04-27
US3557280A (en) 1971-01-19
NO126298B (OSRAM) 1973-01-22
MY7100015A (en) 1971-12-31

Similar Documents

Publication Publication Date Title
FI43622B (OSRAM)
AT281852B (OSRAM)
AU424443B2 (OSRAM)
AU1534566A (OSRAM)
AU218666A (OSRAM)
AU1111066A (OSRAM)
AU1144366A (OSRAM)
AU1393566A (OSRAM)
BE692168A (OSRAM)
BE675376A (OSRAM)
BE637138A (OSRAM)
BE694412A (OSRAM)
BE694236A (OSRAM)
BE694012A (OSRAM)
BE693311A (OSRAM)
BE692974A (OSRAM)
AU1027866A (OSRAM)
BE666282A (OSRAM)
BE691033A (OSRAM)
BE689469A (OSRAM)
BE689049A (OSRAM)
BE688853A (OSRAM)
BE687583A (OSRAM)
BE678955A (OSRAM)
BE675237A (OSRAM)